Adani Green Hits 20 GW Milestone; Gland Pharma Gets USFDA Nod

ECONOMY
Whalesbook Logo
AuthorAarav Shah|Published at:
Adani Green Hits 20 GW Milestone; Gland Pharma Gets USFDA Nod

Adani Green Energy surpassed 20 GW in capacity, while Gland Pharma received a clean USFDA inspection report. Hero MotoCorp's sales grew but missed forecasts, as infrastructure companies secured new orders. Market observers are also analyzing a major stake sale in EPL by its affiliate investor.

Indian markets are reacting to a series of growth milestones and operational updates from major companies today. Adani Green Energy and Gland Pharma are in focus following positive developments, while auto and infrastructure players are drawing attention due to sales figures and new order wins.

Adani Green Energy has hit a major capacity milestone, with its total operational renewable energy footprint crossing 20,000 MW. The company recently operationalized a 139 MW solar project at Khavda in Gujarat. This expansion is part of the firm's broader strategy to scale up capacity in the renewable space. Investors typically monitor these commissioning updates closely as they indicate progress in large-scale, capital-intensive projects.

In the healthcare sector, Gland Pharma received positive news after the US Food and Drug Administration completed a routine GMP inspection of its Visakhapatnam facility. The regulator issued zero Form 483 observations, which is a significant relief. For shareholders, this outcome effectively removes a key regulatory overhang that had previously created uncertainty regarding the facility's operations and potential supply disruptions.

Hero MotoCorp reported sales of 5.68 lakh units for August 2026, marking a 2.65% year-on-year increase. While the volume grew, the figures missed analyst expectations of approximately 5.90 lakh units. A notable area of concern remains the export segment, which saw a 24.6% decline in August. This suggests the company is facing continued pressure in its international markets, a factor that investors may want to monitor alongside domestic demand trends.

Infrastructure companies also announced significant contract wins. Sical Logistics secured a five-year contract worth Rs 534.73 crore from Central Coalfields for overburden removal and coal extraction in Jharkhand. While the order adds to the backlog, investors should monitor the company’s debt position, as high financial leverage—where total liabilities exceed equity—can increase risks if project execution costs rise or face delays. Similarly, ARSS Infrastructure Projects reported a new Rs 130.53 crore railway order, which should provide revenue visibility for upcoming quarters.

In corporate developments, Epsilon Bidco, an affiliate of the Blackstone Group, exited its 26.38% stake in EPL in a transaction valued at over Rs 2,000 crore. The exit saw significant absorption by institutional players, including Quant Mutual Fund and the Abu Dhabi Investment Authority. Moving forward, shareholders will track whether this shift in ownership impacts long-term strategy and how the company manages its operational performance in the coming periods.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.